KLF11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.667900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.289700E-02
Normal-vs-Stage2
5.000400E-02
Normal-vs-Stage3
9.465800E-02
Normal-vs-Stage4
4.344000E-01
Stage1-vs-Stage2
7.087000E-01
Stage1-vs-Stage3
4.361000E-01
Stage1-vs-Stage4
4.389800E-01
Stage2-vs-Stage3
2.834000E-01
Stage2-vs-Stage4
5.223000E-01
Stage3-vs-Stage4
2.868800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.718400E-02
Normal-vs-AfricanAmerican
3.197400E-01
Normal-vs-Asian
8.077700E-02
Caucasian-vs-AfricanAmerican
3.291400E-01
Caucasian-vs-Asian
4.451400E-01
AfricanAmerican-vs-Asian
2.565800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.580100E-02
Normal-vs-Female
4.899600E-02
Male-vs-Female
5.529800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.768200E-01
Normal-vs-Age(41-60Yrs)
1.309620E-01
Normal-vs-Age(61-80Yrs)
2.577700E-02
Normal-vs-Age(81-100Yrs)
1.826230E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.689000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.957000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.651600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.059600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.322700E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.079210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.145800E-02
Normal-vs-Daily Drinker
4.915500E-02
Normal-vs-Weekly Drinker
1.098080E-02
Normal-vs-Occasional Drinker
9.421500E-02
Normal-vs-Social Drinker
1.657040E-01
Non Drinker-vs-Daily Drinker
9.269400E-01
Non Drinker-vs-Weekly Drinker
2.882800E-01
Non Drinker-vs-Occasional Drinker
6.607600E-01
Non Drinker-vs-Social Drinker
9.756000E-01
Daily Drinker-vs-Weekly Drinker
2.102000E-01
Daily Drinker-vs-Occasional Drinker
7.096000E-01
Daily Drinker-vs-Social Drinker
9.682200E-01
Weekly Drinker-vs-Occasional Drinker
1.329790E-01
Weekly Drinker-vs-Social Drinker
3.827000E-01
Occasional Drinker-vs-Social Drinker
7.561600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.083200E-01
Normal-vs-Grade 2
2.028300E-02
Normal-vs-Grade 3
1.374160E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.668100E-02
Grade 1-vs-Grade 3
1.797850E-02
Grade 1-vs-Grade 4
1.083200E-01
Grade 2-vs-Grade 3
6.370000E-01
Grade 2-vs-Grade 4
2.028300E-02
Grade 3-vs-Grade 4
1.374160E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.098200E-02
Normal-vs-NonDiabetic
3.128200E-02
Diabetic-vs-NonDiabetic
6.000200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.361800E-02
Normal-vs-NoPancreatitis
3.738200E-02
Pancreatitis-vs-NoPancreatitis
8.667400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.975700E-03
Normal-vs-N1
7.284000E-02
N0-vs-N1
1.166170E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.589700E-02
Normal-vs-TP53-NonMutant
4.207900E-02
TP53-Mutant-vs-TP53-NonMutant
9.054000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
